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Introduction
Adipose tissue is recognized as a vital player in the mainte-
nance of energy balance, nutrient status, and metabolic homeo-
stasis.1 White adipose tissue (WAT) retains the ability to grow and 
shrink dramatically to meet the energetic needs of an organism; 
however, severe metabolic consequences can result from excessive 
WAT gain, the defining characteristic of obesity, or extreme loss 
of WAT mass, known as lipodystrophy.2,3 These include defects 
in glucose homeostasis, inflammation, and cardiovascular func-
tion.3-6 In order to fully understand these complex multi-organ 
pathologies, studies must be performed in vivo, and our ability 
to address the role of adipose tissue in these systems relies on 
the tools that have been developed to manipulate gene expression 
within adipose tissue in vivo.
Mature adipocytes compose the majority of the volume of 
adipose tissue, and the remaining cell populations in the tissue 
include blood cells, endothelial cells, various immune cell popu-
lations, and adipocyte precursors. Recently, the identification of 
specific murine white adipocyte precursor populations, including 
Lin-:CD29+:CD34+:Sca-1+:CD24+ adipocyte progenitor cells and 
Lin-:CD29+:CD34+:Sca-1+:CD24− preadipocytes,7 has enabled 
further study of the adipocyte lineage in vivo. Furthermore, 
several groups have reported that platelet-derived growth factor 
receptor α (PdgfRα) is expressed on adipocyte precursor cells in 
WAT and traces all adipocytes in normal murine WAT depots,8,9 
which indicates that this promoter is a useful tool for targeting 
the adipocyte cellular lineage.
The Cre/lox system of gene targeting has revolutionized the 
study of tissue-specific function in vivo. Cre recombinase can be 
integrated downstream of an endogenous promoter, often termed 
a “knock-in”, or it can be placed under control of a promoter 
fragment which is then integrated into the genome at a random 
site. The length of this promoter sequence and the location of 
the integration site can affect the expression pattern of the Cre 
transgene, and may affect the fidelity of Cre expression compared 
with the expression of the endogenous gene.10 Additionally, tem-
poral control over gene expression can be achieved with inducible 
targeting models such as doxycycline-regulated Cre expression or 
tamoxifen-sensitive Cre. When applying these techniques, how-
ever, it is important to keep in mind the limitations and pitfalls 
of these approaches including the erroneous expression of Cre 
transgenes, the varying sensitivity of different genomic sites to 
Cre-mediated loxP recombination, and the potential for changes 
in Cre expression or efficacy over several generations of mouse 
colony maintenance.11,12
To facilitate the study of adipocyte function in physiologi-
cally relevant contexts, several adipocyte-specific promoters have 
been generated to drive the expression of Cre recombinase in adi-
pose tissues. Of these, the most commonly used Cre transgenes 
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The study of adipose tissue in vivo has been significantly advanced through the use of genetic mouse models. While 
the aP2-creBI and aP2-creSalk lines have been widely used to target adipose tissue, the specificity of these lines for adipo-
cytes has recently been questioned. here we characterize cre recombinase activity in multiple cell populations of the 
major adipose tissue depots of these and other cre lines using the membrane-Tomato/membrane-GFP (mT/mG) dual 
fluorescent reporter. We find that the aP2-creBI and aP2-creSalk lines lack specificity for adipocytes within adipose tissue, 
and that the aP2-creBI line does not efficiently target adipocytes in white adipose depots. Alternatively, the Adiponectin-
creeRT line shows high efficiency and specificity for adipocytes, while the PdgfRα-creeRUcL and PdgfRα-creeRJhU lines 
do not efficiently target adipocyte precursor cells in the major adipose depots. Instead, we show that the PdgfRα-cre line 
is preferable for studies targeting adipocyte precursor cells in vivo.©
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were created from the promoter of the fatty acid binding protein 
4 (Fabp4) gene which encodes adipocyte protein 2 (aP2).13 Two 
separate lines (aP2-CreBI and aP2-CreSalk) were generated14,15 and 
widely used in studies to target adipocytes in vivo.16 However, 
these lines have been shown to have Cre activity in other tissues 
and cell types, including brain, endothelial cells, macrophages, 
adipocyte precursors and embryonic tissues.16-19 Alternatively, 
the promoter of the adipocyte-specific protein Adiponectin 
(encoded by Adipoq) has been used to generate Cre lines for the 
study of adipocyte function.20,21 These Adiponectin-Cre mouse 
lines have been shown by multiple groups to be highly specific 
to adipose tissue.16,18,20 To identify the most useful tools for tar-
geting the adipocyte lineage in vivo, we sought to investigate 
the recombination efficiency and specificity of commonly used 
Cre lines, using a membrane-targeted dual fluorescent reporter 
model to quantitatively assess Cre recombinase activity in adi-
pose tissues.
Here we characterize the recombination of specific cell pop-
ulations within adipose tissue in the aP2-CreBI and aP2-CreSalk 
lines, as well as the tamoxifen-inducible Adiponectin-CreERT 
and PdgfRα-CreERT lines. We find incomplete targeting of 
adipocytes and a lack of specificity with the aP2-CreBI and aP2-
CreSalk lines, and remarkably low recombination efficiency in adi-
pocyte precursors in PdgfRα-CreER lines. Finally, we show that 
the Adiponectin-CreERT is a useful inducible model for target-
ing mature adipocytes, while the PdgfRα-Cre is useful for study-
ing the adipocyte lineage in vivo.
Results
To characterize the pattern of Cre expression in the aP2-
Cre lines, we crossed each of these lines to the dual fluorescent 
reporter model (mT/mG) that we have previously used to per-
form lineage tracing of white adipose tissue.9,22 This reporter 
expresses membrane-targeted tdTomato (mT), and the expres-
sion of Cre recombinase results in the excision of the tdTomato 
cassette, which then permits the expression of membrane-tar-
geted eGFP (mG). Since these fluorescent proteins are mem-
brane-targeted, this model provides clear fluorescently labeled 
cellular boundaries, facilitating the identification of adipocytes 
in which Cre-mediated recombination has occurred. When we 
analyzed the pattern of Cre expression in several adipose depots 
of aP2-CreBI; mT/mG mice, we found that few adipocytes were 
labeled in WAT depots, while approximately half of the adipo-
cytes in the intrascapular brown adipose tissue (iBAT) depot 
were labeled (Fig. 1A and B). Additionally, flow cytometry anal-
ysis indicated that a large percentage of endothelial cells were 
labeled in both WAT and BAT depots in the aP2-CreBI line, 
while the adipocyte precursor populations were not labeled in 
WAT depots (Fig. 1B). Further confocal analysis confirmed that 
the majority of eGFP-positive cells in SWAT co-stained with the 
endothelial stain GSIB4 (Fig. 1C). Finally, we observed negli-
gible labeling of both liver and skeletal muscle cells of these mice 
(data not shown). These data indicate that while this line was 
originally shown to efficiently label adipocytes,14 it now targets 
primarily brown adipocytes and endothelial cells within adipose 
tissue.
We next characterized Cre expression in the aP2-CreSalk line 
using the mT/mG fluorescent reporter. We found that the per-
centage of adipocytes labeled by this line in WAT depots was 
much higher than the aP2-CreBI line, and varied between 50 and 
80 percent (Fig. 2A and B). Brown adipocytes were labeled to 
a similar degree (Fig. 2A and B). While there was some label-
ing in the adipocyte precursor populations in all depots, we also 
observed some labeling in blood lineage cells and significant 
labeling of CD31+ endothelial cells in all adipose depots analyzed 
(Fig. 2B), again indicating a lack of specificity for the adipocyte 
lineage in the aP2-CreSalk line. However, we observed negligible 
Cre-mediated recombination in cells of the liver and skeletal 
muscle of these mice (data not shown).
The promoter for adiponectin, a hormone secreted by 
mature adipocytes, has been used by multiple groups to 
Figure 1. aP2-creBI primarily labels endothelial cells and brown adipo-
cytes. (A) confocal microscopy of the indicated adipose tissue depots 
from aP2-creBI; mT/mG mice. (B) Quantification of cells displaying cre-
mediated expression of eGFP in cell populations of the indicated adipose 
tissue depots (n = 3). (C) confocal microscopy of SWAT from aP2-creBI; 
mT/mG mice stained with isolectin GSIB4 to label endothelial cells. Scale 
bars in (A and C) are 100 μm. SWAT, subcutaneous WAT; GWAT, gonadal 
WAT; RWAT, retroperitoneal WAT; MWAT, mesenteric WAT; BAT, brown 
adipose tissue; SVF, stromal vascular fraction.©
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generate adipocyte-specific Cre lines.20,21 The most widely used 
Adiponectin-CreR line12 has been shown several times to be spe-
cific to adipocytes,9,16,18 and useful for targeting mature adipo-
cytes in vivo. To characterize inducible Cre expression in a new 
Adiponectin-CreER line generated with the same BAC used to 
create the Adiponectin-CreR mice, we crossed this line to the 
mT/mG reporter line and treated mice with 50 mg/kg tamoxi-
fen for 6 d. Before tamoxifen treatment, no adipocyte label-
ing was observed (Fig. S1A), and after tamoxifen treatment, 
adipocyte recombination was nearly 100% in all WAT depots 
analyzed, with negligible recombination in any other cell popu-
lation, and greater than 85% recombination was observed in 
brown adipocytes (Fig. 3A and B). Importantly, no cells within 
the adipose SVF displayed Cre-mediated recombination in 
this model, including the adipocyte precursor populations, 
(Fig. 3B), confirming the specificity of this promoter for 
mature adipocytes.
We and other groups have shown that PdgfRα is expressed on 
adipocyte precursor populations within WAT,8,9 and that almost 
all of the adipocyte precursors are labeled in PdgfRα-Cre; mT/
mG mice. In addition, the vast majority of the cells displaying 
Cre-recombination within WAT SVF of PdgfRα-Cre; mT/mG 
mice are adipocyte precursors.9 To determine whether this Cre 
line may be useful for metabolic studies targeting the adipocyte 
lineage, but not other major metabolic tissues, we assessed Cre-
mediated recombination in the cells of the muscle and liver of 
PdgfRα-Cre; mT/mG mice. We found low levels of recombina-
tion in both of these tissues (Fig. 4A), indicating that the muscle 
and liver are minimally targeted by the PdgfRα promoter. These 
Figure  2. aP2-creSalk labels multiple cell populations within adipose 
tissue. (A) confocal microscopy of the indicated adipose tissue depots 
from aP2-creSalk; mT/mG mice. (B) Quantification of cells displaying cre-
mediated expression of eGFP in cell populations of the indicated adipose 
tissue depots (n = 3). Scale bars in (A) are 100 μm. SWAT, subcutaneous 
WAT; GWAT, gonadal WAT; RWAT, retroperitoneal WAT; MWAT, mesenteric 
WAT; BAT, brown adipose tissue; SVF, stromal vascular fraction.
Figure 3. Adiponectin-creeRT labels mature adipocytes. (A) confocal 
microscopy of the indicated adipose tissue depots from Adiponectin-
creeRT; mT/mG mice after tamoxifen treatment. (B) Quantification of 
cells displaying cre-mediated expression of eGFP in cell populations of 
the indicated adipose tissue depots (n = 3). Scale bars in (A) are 100 μm. 
SWAT, subcutaneous WAT; GWAT, gonadal WAT; RWAT, retroperitoneal 
WAT; MWAT, mesenteric WAT; BAT, brown adipose tissue; SVF, stromal 
vascular fraction.©
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data suggest that the PdgfRα-Cre line may be appropriate for 
functional studies of the adipocyte cellular lineage in vivo.
Inducible versions of the PdgfRα-Cre mouse line have been 
generated by both the Richardson group23 (PdgfRα-CreERUCL) 
and the Bergles group24 (PdgfRα-CreERJHU). Both of these lines 
have previously been shown to label oligodendrocyte precursors in 
the brain.23,24 The PdgfRα-CreERUCL line has been used to label 
adipocyte lineage cells in WAT8 and fibroblast-like cells in the 
skin,25 although with variable efficiency. To assess the potential 
utility of both of these lines for the study of adipocyte precursors 
in WAT depots in vivo, we treated PdgfRα-CreERUCL; mT/mG 
and PdgfRα-CreERJHU; mT/mG mice with 50 mg/kg tamoxifen 
daily for 6 d and subsequently analyzed the percentage of adi-
pocyte precursor cells displaying Cre-mediated recombination in 
the skin and primary WAT depots of these mice. In tamoxifen-
treated PdgfRα-CreERJHU; mT/mG mice, we observed a high level 
of GFP-positive cells in the dermal layer of the skin (Fig. 4B), a 
region known to contain PdgfRα-Cre-expressing cells including 
an adipogenic population;25,26 however, less than 1% of the intra-
dermal adipocyte precursor cells were labeled (data not shown). 
When we analyzed the stromal vascular fraction of WAT depots 
in PdgfRα-CreERUCL; mT/mG mice, we observed very low rates 
of recombination (less than 3%) in adipocyte precursor popula-
tions of both GWAT and SWAT, with only marginally better 
recombination percentages in the SWAT of PdgfRα-CreERJHU; 
mT/mG mice (Fig. 4C). Treatment of PdgfRα-CreERJHU; mT/
mG mice with a higher tamoxifen dose (300 mg/kg for 5 d), did 
not improve the recombination efficiency (Fig. S1C), indicating 
that Cre activity in adipocyte precursors in these lines is insuf-
ficient for assessing gene function in adipocyte precursors in vivo.
Discussion
Tools for the genetic targeting of adipose tissue in vivo are 
essential for the study of adipose function and metabolic disease. 
Figure 4. PdgfRα-creeR does not efficiently label adipocyte precursor cells. (A) confocal microscopy of the liver and skeletal muscle (gastrocnemius) 
from PdgfRα-cre; mT/mG mice. (B) Quantification of cells displaying cre-mediated expression of eGFP in liver and skeletal muscle of PdgfRα-cre; mT/
mG mice (n = 3). (C) Immunofluorescence image of the back skin of PdgfRα-creeRUcL; mT/mG mouse after tamoxifen injection showing recombination 
in fibroblastic cells of the upper dermis. Perilipin staining of adipocytes indicates the location of the adipocyte layer within the dermal compartment. 
Representative image from 2 animals. (D) Quantification of cells displaying cre-mediated expression of eGFP in the adipocyte precursor population of 
the indicated depots of PdgfRα-creeRUcL; mT/mG and PdgfRα-creeRJhU; mT/mG mice after daily treatment of 50mg/kg tamoxifen for 6 d (n = 3–4). Scale 
bars in (A and C) are 100 μm. SWAT, subcutaneous WAT; GWAT, gonadal WAT; SVF, stromal vascular fraction.©
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Consistent with previous reports,16,17 our data show that the aP2-
CreBI line and the aP2-CreSalk line are not specific to adipocytes. 
However, contrary to previous studies using cytoplasmic LacZ 
cre reporters,18 quantitative analysis of adipocyte labeling with 
the mT/mG reporter indicates that the aP2-CreBI line does not 
label the majority of adipocytes in WAT depots. Since this could 
be due to a shift in the Cre expression pattern in these lines over 
generations,12 these data emphasize the importance of monitor-
ing recombination within a line over time. Additionally, these 
data highlight the importance of determining the specificity of 
Cre-recombination to the cell types of interest in a particular tis-
sue in studies of cellular lineage dynamics and cell function.
We and others have previously found that the Adiponectin-
CreR effectively targets mature adipocytes,9,16,18,20 and we show 
here that the Adiponectin-CreER line can be used to efficiently 
target adipocytes in an inducible manner. This model can be 
applied in studies of adult animals in which developmental 
defects in adipose tissue could present confounding effects, and 
also provides the temporal control necessary to perform quan-
titative pulse-labeling studies when coupled with the mT/mG 
reporter.
The PdgfRα-CreER model would also be a valuable tool for 
targeting adipocyte precursor cells. While one group has used 
very high doses of tamoxifen to achieve partial recombination 
in WAT-resident APs,8 we show here that in our hands neither 
of the existing PdgfRα-CreER lines efficiently label this popula-
tion, despite labeling of other PdgfRα-expressing populations in 
the dermis (Fig. 4). Given that both of the promoter sequences 
used to generate the PdgfRα-CreER lack a region of at least 
60 kb upstream of the PdgfRα gene compared with the PdgfRα-
Cre construct, this low labeling efficiency may be due to the lack 
of cis-regulatory elements that are normally necessary to drive 
expression from the PdgfRα promoter in certain cell popula-
tions.23,24,27 Another potential factor in the difference in labeling 
between the PdgfRα-CreER and PdgfRα-Cre lines is differences 
in integration sites in the genome. Regardless of the reason, the 
low labeling efficiency in these PdgfRα-CreER lines indicates 
that they are not useful for quantitative adipocyte lineage studies 
or for study of gene function in the adipocyte lineage.
Even when the promoter region used to drive transgene 
expression is large, differences in enhancer activity or positional 
effects of the insertion site can cause the expression of the trans-
gene to differ from the endogenous gene. This appears to be the 
case for the PdgfRα-Cre line, which efficiently labels adipocyte 
precursors.9 During murine embryonic development, staining for 
endogenous PdgfRα and experiments utilizing a knock-in fluo-
rescent reporter have shown that PdgfRα is expressed in regions 
of the endoderm, mesoderm and ectoderm, with the most promi-
nent expression occurring in mesodermal tissues.28-31 Starting at 
embryonic day 8, PdgfRα is expressed throughout the somites,28 
which give rise several mesodermal tissues including the skeletal 
muscle, dermis, and cartilage. However, in adult PdgfRα-Cre 
mice, the broad recombination that would be expected given 
this embryonic expression pattern is not observed. For example, 
adult skeletal muscle displays a low level of Cre-mediated recom-
bination in the PdgfRα-Cre line. These data suggest that the 
expression of Cre from the PdgfRα promoter in the PdgfRα-
Cre model does not mimic these early embryonic expression pat-
terns (Fig. 4). This restricted expression may be due to a lack of 
promoter and/or enhancer elements in the PdgfRα-Cre genetic 
construct that are required to induce embryonic expression of the 
gene. The PdgfRα-Cre model has been shown to label other cell 
populations such as the Muller glial cells of the retina,27 but our 
data show that it is not significantly expressed in the parenchy-
mal cells of other major metabolic organs such as the liver and 
skeletal muscle. These findings indicate that PdgfRα-Cre should 
not have significant “off target” effects in other metabolic tissues. 
However, the known Cre expression from this promoter in other 
cell types, such as oligodendrocytes,23 should be considered when 
interpreting results from this model.
Another caveat that must be considered when using either the 
PdgfRα or the Adiponectin promoters for the study of adipose 
function is that these models express Cre recombinase in both 
white and brown adipocytes. There are not currently any models 
known to specifically target WAT without targeting BAT, and 
the promoters known to target BAT also target either muscle and 
subsets of white adipocytes32-34 or target both beige and brown 
adipocytes.35 Therefore, we conclude that PdgfRα-Cre is cur-
rently the best model available for the targeting of adipocyte 
lineage cells in adipose depots in vivo, while the Adiponectin-
CreR and Adiponectin-CreER are effective for targeting mature 
adipocytes.
Materials and Methods
All animal studies followed guidelines issued by Yale 
University’s Institutional Animal Care and Use Committee 
(IACUC). aP2-CreBI mice were a generous gift from Dr Barbara 
Kahn, obtained in October 2013. The PdgfRα-CreERUCL mouse 
line23 was independently obtained from Dr Anne Perl and 
Dr Dana McTigue. The aP2-CreSalk mice (005069), PdgfRα-
Cre mice (013148), PdgfRα-CreERJHU mice (018280), and mT/
mG mice (007676) were purchased from Jackson Laboratories. 
AdiponectinCre-ERT mice (024671) are now available at Jackson 
Laboratories. Except for the Adiponectin-CreERT and PdgfRα-
CreER lines, all mice analyzed were males between 4 and 6 wk 
of age.
For Adiponectin-CreERT experiments, 8-wk-old male mice 
were given daily intraperitoneal injections of 50 mg/kg tamoxifen 
in vegetable oil for 6 d. Mice were then allowed to recover for 
one week, and then sacrificed. For PdgfRα-CreER experiments, 
where indicated, mice between 5 and 10 wk of age were given 
either intraperitoneal injections of 50 mg/kg tamoxifen in veg-
etable oil daily for 6–7 d or oral gavage of 300 mg/kg tamoxifen 
in vegetable oil daily for 5 d.
Confocal microscopy and flow cytometry were performed as 
described.9,36,37 For immunofluorescence, 14 μm skin sections 
were fixed with 4% paraformaldehyde and incubated with pri-
mary antibodies against GFP (chicken, Abcam, 1:1000) and 
perilipin A (goat, Abcam, 1:1000) overnight at 4 °C followed 
by incubation with alexa fluor-conjugated secondary antibodies.©
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